Doucet G, Descarries L, Garcia S
Neuroscience. 1986 Oct;19(2):427-45. doi: 10.1016/0306-4522(86)90272-1.
Conditions leading to specific and integral visualization of dopamine axon terminals (varicosities) were tested in adult rat cerebral hemisphere slices incubated with [3H]dopamine and processed for high resolution radioautography. Specific visualization of the dopamine endings was achieved after incubation with 10(-6) M [3H]dopamine in the presence of a monoamine oxidase inhibitor (pargyline 10(-4) M), and of desipramine (5 X 10(-6) M), an inhibitor of catecholamine uptake by noradrenaline and serotonin neurons. [3H]Dopamine varicosity labeling was eliminated by the addition of 5 X 10(-5) M benztropine (an inhibitor of catecholamine uptake by catecholamine neurons), and was almost absent when dopamine nerve cell bodies of the midbrain had been previously destroyed with 6-hydroxydopamine. In dopamine-denervated neostriatum incubated without desipramine, a second set of labeled terminals was also visible. These were identified as serotoninergic, since their labeling was suppressed by citalopram, an inhibitor of monoamine uptake highly specific for serotonin neurons. There was no desipramine-sensitive but citalopram-resistant varicosity labeling suggestive of neostriatal noradrenaline innervation. In normal striatum, incubation at 35 degrees C always resulted in a labeling of dopamine varicosities restricted to a narrow band which followed the contours and cut surface of this anatomical region. This unusual distribution was the result of an uptake barrier generated by the tightly packed dopamine varicosities. Indeed, the striatal dopamine varicosity labeling was more widespread after partial 6-hydroxydopamine denervation or in normal tissue incubated either with a higher [3H]dopamine concentration (5 X 10(-6) M), in the presence of relatively low benztropine concentrations (10(-5) M), or at lower temperature (15 degrees C). Material incubated at 15 degrees C for 90 min was suitable for purposes of quantification: labeled varicosities were then visualized throughout the striatum and across the full thickness of the slices; moreover, the number of labeled varicosities plotted against radioautographic exposure time increased in parallel and reached a plateau at the same time in neostriatal sectors with widely different innervation densities. At a rostral transverse level across neostriatum, the dorsolateral quadrant showed hyperdense "patches" of labeled terminals distinguishable from an already dense surrounding "matrix", whereas, ventromedially, the dopamine innervation appeared more uniform and somewhat less dense.(ABSTRACT TRUNCATED AT 400 WORDS)
在含有[3H]多巴胺的成年大鼠脑半球切片中进行实验,测试能够实现多巴胺轴突终末(膨体)特异性和完整可视化的条件,并对其进行高分辨率放射自显影处理。在单胺氧化酶抑制剂(10(-4) M 优降宁)和去甲丙咪嗪(5×10(-6) M,去甲肾上腺素和5-羟色胺神经元摄取儿茶酚胺的抑制剂)存在的情况下,用10(-6) M [3H]多巴胺孵育后,可实现多巴胺终末的特异性可视化。加入5×10(-5) M苯海索(儿茶酚胺神经元摄取儿茶酚胺的抑制剂)可消除[3H]多巴胺膨体标记,而当中脑多巴胺神经细胞体预先用6-羟基多巴胺破坏后,[3H]多巴胺膨体标记几乎消失。在未添加去甲丙咪嗪孵育的多巴胺去神经支配的新纹状体中,还可见另一组标记终末。这些终末被鉴定为5-羟色胺能终末,因为它们的标记被西酞普兰(一种对5-羟色胺神经元高度特异的单胺摄取抑制剂)所抑制。没有发现对去甲丙咪嗪敏感但对西酞普兰耐药的膨体标记提示新纹状体去甲肾上腺素神经支配。在正常纹状体中,35℃孵育总是导致多巴胺膨体标记局限于一个窄带,该窄带沿此解剖区域的轮廓和切面分布。这种不寻常的分布是由紧密排列的多巴胺膨体产生的摄取屏障所致。实际上,在部分6-羟基多巴胺去神经支配后,或在较高[3H]多巴胺浓度(5×10(-6) M)、相对较低苯海索浓度(10(-5) M)或较低温度(15℃)孵育的正常组织中,纹状体多巴胺膨体标记更广泛。在15℃孵育90分钟的材料适用于定量分析:此时,标记的膨体在整个纹状体和切片的全层中均可可视化;此外,在神经支配密度差异很大的新纹状体区域,绘制的标记膨体数量与放射自显影片曝光时间呈平行增加,并同时达到平稳期。在新纹状体的嘴侧横断面上,背外侧象限显示出标记终末的高密度“斑块”,可与已经密集的周围“基质”区分开,而在腹内侧,多巴胺神经支配显得更均匀且密度稍低。(摘要截于400字)